Paul Goldsmith

Paul Goldsmith

Eli Lilly and Company - Indianapolis / United States
Natural Sciences / Chemical Sciences
AD Scientific Index ID: 4388918
-
person_outline Paul Goldsmith's MOST POPULAR ARTICLES
1-) Remarkably Stable (Me3Al)2⋅DABCO and Stereoselective Nickel‐Catalyzed AlR3 (R=Me, Et) Additions to AldehydesK Biswas, O Prieto, PJ Goldsmith, S WoodwardAngewandte Chemie International Edition 44 (15), 2232-2234, 20051472005
2-) Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseasesCC Felder, PJ Goldsmith, K Jackson, HE Sanger, DA Evans, AJ Mogg, ...Neuropharmacology 136, 449-458, 2018842018
3-) Rational design of phosphoinositide 3-kinase α inhibitors that exhibit selectivity over the phosphoinositide 3-kinase β isoformTP Heffron, BQ Wei, A Olivero, ST Staben, V Tsui, S Do, J Dotson, ...Journal of medicinal chemistry 54 (22), 7815-7833, 2011822011
4-) Discovery of novel PI3-kinase δ specific inhibitors for the treatment of rheumatoid arthritis: taming CYP3A4 time-dependent inhibitionBS Safina, S Baker, M Baumgardner, PM Blaney, BK Chan, YH Chen, ...Journal of medicinal chemistry 55 (12), 5887-5900, 2012752012
5-) Benzopyran and benzoxepin PI3K inhibitor compounds and methods of useS Do, R Goldsmith, T Heffron, A Kolesnikov, S Staben, AG Olivero, M Siu, ...US Patent 7,928,248, 2011682011